Latest Retirement News

Axtec has proposed fintech founder Andy Taylor as its next Managing Director and CEO, pairing the appointment with a A$1 million share placement and a plan to expand beyond real estate payments. The leadership change remains conditional on Taylor completing his cornerstone investment and finalising employment terms.

Scentre Group has reaffirmed its 2026 earnings and distribution targets after reporting higher customer traffic, stronger business partner sales and record-level occupancy across its Westfield portfolio. The update also puts a number on the group’s exposure to David Jones and details fresh debt funding and asset recycling.

Scentre Group has reaffirmed its 2026 funds-from-operations and distribution targets after reporting stronger visitation, sales and leasing metrics across its Westfield portfolio. Exposure to David Jones remains material in floor space but limited in earnings terms, with rent paid through September.

Prudential Financial delivered lower third-quarter adjusted earnings as a sales suspension in Japan cut into an otherwise mixed performance. PGIM attracted strong third-party inflows and US annuity sales reached a record, but the company’s central earnings engine weakened year on year.

Aptiv delivered 2% third-quarter revenue growth and returned to statutory profit, while maintaining its full-year 2026 outlook after the spin-off of its Electrical Distribution Systems business. The result was supported by North American growth and share buybacks, but adjusted EBITDA and margins declined.

Apollo delivered record fee-related earnings and crossed US$1 trillion in assets under management, but higher interest rates pushed the alternative asset manager to a US$1.1 billion GAAP loss. The quarter also brought record origination and a quarterly dividend of US$0.5625 per share.

Clever Culture Systems has secured $2.6 million to develop APAS Revolution, a smaller benchtop system aimed at pharmaceutical manufacturers not served by its existing platform. The funding combines a discounted share placement with new debt, while commercial launch is targeted for the first half of 2028.

Lumentum delivered a 136.5% year-on-year revenue surge in fiscal Q1 2027 and forecast a further step-up to as much as US$1.625 billion in the next quarter. Management also disclosed purchase commitments exceeding US$5 billion linked to a second major NPO/CPO win, though the timing and enforceability of those commitments were not detailed.

Neurizon Therapeutics has secured A$4.3 million through a discounted placement and is seeking another A$2.0 million from eligible shareholders, while redeeming its remaining Obsidian convertible notes. The move removes current note-conversion dilution, but shifts funding risk towards equity holders ahead of a pivotal NUZ-001 trial readout.

Image Resources delivered Atlas production above the midpoint of annual guidance, but port delays and an A$8.9 million quarterly operating cash outflow left the company with A$9.0 million and less than one quarter of funding. A proposed LB Group transaction may provide further support, although it remains subject to binding documents and approvals.

Zimplats will replace long-serving chief executive Alexander Mhembere with internal successor Dr Stanley Segula from 1 November. The handover preserves operational continuity while Mhembere remains chairman of the company’s Zimbabwean operating subsidiary.

InteliCare ended the September quarter with A$1.394 million in cash after an operating cash outflow of A$1.271 million, leaving just 1.10 quarters of estimated funding. The company is relying on customer receipts from expanding deployments, while continuing to assess funding options.